UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

Nutrition, metabolism, and cardiovascular diseases, 2018-06, Vol.28 (6), p.533-542

2018

Link zum Volltext

Verfügbarkeit prüfen

Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies

Cephalalgia, 2015-02, Vol.35 (2), p.118-131

2015

Link zum Volltext

Verfügbarkeit prüfen

The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice

British journal of dermatology (1951), 2021-03, Vol.184 (3), p.581-583

2021

Link zum Volltext

Verfügbarkeit prüfen

The Approaches to Assess Robustness of Disproportionality Findings in Pharmacovigilance. A Meta-Epidemiological Research

Drug safety, 2022-10, Vol.45 (10), p.1246-1247

2022

Link zum Volltext

Verfügbarkeit prüfen

Medication use in Italian nursing homes: preliminary results from the national monitoring system

Frontiers in pharmacology, 2023-05, Vol.14, p.1128605-1128605

2023

Link zum Volltext

Verfügbarkeit prüfen

Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K+ Channel Blockers

Journal of medicinal chemistry, 2002-08, Vol.45 (18), p.3844-3853

2002

Link zum Volltext

Verfügbarkeit prüfen

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems

Nutrition, metabolism, and cardiovascular diseases, 2017-12, Vol.27 (12), p.1098-1107

2017

Link zum Volltext

Verfügbarkeit prüfen

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database

Acta diabetologica, 2013-08, Vol.50 (4), p.569-577

2013

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

Nutrition, metabolism, and cardiovascular diseases, 2016-05, Vol.26 (5), p.380-386

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction

Journal of the European Academy of Dermatology and Venereology, 2020-08, Vol.34 (8), p.e430-e431

2020

Link zum Volltext

Verfügbarkeit prüfen

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

Medicinal research reviews, 2005-03, Vol.25 (2), p.133-166

2005

Link zum Volltext

Verfügbarkeit prüfen

Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics

Alimentary pharmacology & therapeutics, 2004-02, Vol.19 (4), p.379-390

2004

Link zum Volltext

Verfügbarkeit prüfen

Safety Profile of Sodium-Glucose Co-Transporter-2 Inhibitors: A Global Analysis of Pharmacovigilance Databases

Clinical therapeutics, 2017-08, Vol.39 (8), p.e38-e39

2017

Link zum Volltext

Verfügbarkeit prüfen

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution

Neurogastroenterology and motility, 2017-02, Vol.29 (2), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes an overview

Drug safety, 2002, Vol.25 (4), p.263-286

2002

Link zum Volltext

Verfügbarkeit prüfen

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit

Italian journal of pediatrics, 2017-04, Vol.43 (1), p.37-9, Article 37

2017

Link zum Volltext

Verfügbarkeit prüfen

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

European journal of clinical pharmacology, 2000-04, Vol.56 (1), p.1-18

2000

Link zum Volltext

Verfügbarkeit prüfen

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

European journal of clinical pharmacology, 2001-06, Vol.57 (3), p.185-209

2001

Link zum Volltext

Verfügbarkeit prüfen

Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system

Clinical therapeutics, 2015-08, Vol.37 (8), p.e106-e106

2015

Link zum Volltext

Verfügbarkeit prüfen

Hospitalisations by Drug interactions with nsaids in elderly poly-treated patients: outcome research on administrative databases

Clinical therapeutics, 2015-08, Vol.37 (8), p.e101-e102

2015

Link zum Volltext

Verfügbarkeit prüfen

Oral Presentation: Investigating Hidden Networks in Spontaneous Reporting Systems

Drug safety, 2022-10, Vol.45 (10), p.1119-1120

2022

Link zum Volltext

Verfügbarkeit prüfen

Oppenauer's oxidation by paraformaldehyde of piperonyl alcohol to heliotropine

Catalysis today, 2009-02, Vol.140 (1), p.112-116

2009

Link zum Volltext

Verfügbarkeit prüfen

PP016—Exposure to antipsychotics with pro-arrhythmic risk: Combining adverse drug reactions with drug utilization data

Clinical therapeutics, 2013-08, Vol.35 (8), p.e22-e22

2013

Link zum Volltext

Verfügbarkeit prüfen

Hyperacute Multisystem Toxicities with Immune Checkpoint Inhibitors in the FDA Adverse Event Reporting System: The Immune-Adversome

Drug safety, 2022-10, Vol.45 (10), p.1133-1133

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System

Drug safety, 2022-10, Vol.45 (10), p.1134-1134

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(45)
Humans
(43)
Pharmacology & Pharmacy
(20)
Male
(16)
Female
(15)
Pharmacovigilance
(15)
Adult
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Italy
(11)
Middle Aged
(11)
Pharmacology. Drug Treatments
(11)
Aged
(10)
Drug Utilization
(9)
Medicin Och Hälsovetenskap
(9)
Pharmacology
(9)
Adverse Events
(8)
Public, Environmental & Occupational Health
(8)
Side Effects
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies

The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice

The Approaches to Assess Robustness of Disproportionality Findings in Pharmacovigilance. A Meta-Epidemiological Research

Medication use in Italian nursing homes: preliminary results from the national monitoring system

Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K+ Channel Blockers

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics

Safety Profile of Sodium-Glucose Co-Transporter-2 Inhibitors: A Global Analysis of Pharmacovigilance Databases

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes an overview

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system

Hospitalisations by Drug interactions with nsaids in elderly poly-treated patients: outcome research on administrative databases

Oral Presentation: Investigating Hidden Networks in Spontaneous Reporting Systems

Oppenauer's oxidation by paraformaldehyde of piperonyl alcohol to heliotropine

PP016—Exposure to antipsychotics with pro-arrhythmic risk: Combining adverse drug reactions with drug utilization data

Hyperacute Multisystem Toxicities with Immune Checkpoint Inhibitors in the FDA Adverse Event Reporting System: The Immune-Adversome

Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System

Suchergebnisse filtern